These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

267 related items for PubMed ID: 19076433

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [The molecular bases of Huntington's disease: the role played by oxidative stress].
    Tasset I, Sánchez F, Túnez I.
    Rev Neurol; ; 49(8):424-9. PubMed ID: 19816846
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Recent advances on the pathogenesis of Huntington's disease.
    Petersén A, Mani K, Brundin P.
    Exp Neurol; 1999 May; 157(1):1-18. PubMed ID: 10222105
    [Abstract] [Full Text] [Related]

  • 5. Proteomic and oxidative stress analysis in human brain samples of Huntington disease.
    Sorolla MA, Reverter-Branchat G, Tamarit J, Ferrer I, Ros J, Cabiscol E.
    Free Radic Biol Med; 2008 Sep 01; 45(5):667-78. PubMed ID: 18588971
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Mechanisms of disease: Histone modifications in Huntington's disease.
    Sadri-Vakili G, Cha JH.
    Nat Clin Pract Neurol; 2006 Jun 01; 2(6):330-8. PubMed ID: 16932577
    [Abstract] [Full Text] [Related]

  • 9. The therapeutic role of creatine in Huntington's disease.
    Ryu H, Rosas HD, Hersch SM, Ferrante RJ.
    Pharmacol Ther; 2005 Nov 01; 108(2):193-207. PubMed ID: 16055197
    [Abstract] [Full Text] [Related]

  • 10. Oxidative damage and metabolic dysfunction in Huntington's disease: selective vulnerability of the basal ganglia.
    Browne SE, Bowling AC, MacGarvey U, Baik MJ, Berger SC, Muqit MM, Bird ED, Beal MF.
    Ann Neurol; 1997 May 01; 41(5):646-53. PubMed ID: 9153527
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Study of oxidative damage and antioxidant systems in two Huntington's disease rodent models.
    Pérez-Severiano F, Montes S, Gerónimo-Olvera C, Segovia J.
    Methods Mol Biol; 2013 May 01; 1010():177-200. PubMed ID: 23754226
    [Abstract] [Full Text] [Related]

  • 15. The R6 lines of transgenic mice: a model for screening new therapies for Huntington's disease.
    Gil JM, Rego AC.
    Brain Res Rev; 2009 Mar 01; 59(2):410-31. PubMed ID: 19118572
    [Abstract] [Full Text] [Related]

  • 16. Huntington's disease.
    Grove M, Vonsattel JP, Mazzoni P, Marder K.
    Sci Aging Knowledge Environ; 2003 Oct 29; 2003(43):dn3. PubMed ID: 14586062
    [Abstract] [Full Text] [Related]

  • 17. Huntington's disease - new perspectives based on neuroendocrine changes in rodent models.
    Petersén A, Hult S, Kirik D.
    Neurodegener Dis; 2009 Oct 29; 6(4):154-64. PubMed ID: 19521064
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Huntington's disease: the current state of research with peripheral tissues.
    Sassone J, Colciago C, Cislaghi G, Silani V, Ciammola A.
    Exp Neurol; 2009 Oct 29; 219(2):385-97. PubMed ID: 19460373
    [Abstract] [Full Text] [Related]

  • 20. The role of iron imaging in Huntington's disease.
    van den Bogaard SJ, Dumas EM, Roos RA.
    Int Rev Neurobiol; 2013 Oct 29; 110():241-50. PubMed ID: 24209441
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.